explore -WSS

explore

author：fashion 2025-10-01 04:10:16 - browse：3

Adam's take main illustration — Molly Ferguson/STAT

This week, a preview of the TUDCA study in ALS and thoughts on how it might impact Amylyx Pharmaceuticals. Also, I chatted with CRISPR Therapeutics CEO Sam Kulkarni about its new investor. Read to the end for some burning questions, random thoughts.

The next ALS data readout — overdue but important

A European academic consortium is expected to announce results soon from a clinical trial investigating the use of a widely available nutritional supplement called tauroursodeoxycholic acid, or TUDCA, in people living with ALS. The outcome of the TUDCA-ALS study could have implications for Amylyx Pharmaceuticals, because TUDCA is one of the two main ingredients in Relyvrio, the company’s approved drug for ALS.

In a recent interview at Amylyx’s Kendall Square headquarters, co-CEOs Justin Klee and Josh Cohen mostly downplayed the suggestion that results from the randomized, placebo-controlled TUDCA study might affect Relyvrio negatively, or even positively.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Brain MRIs reveal impact of 'toxic stress' on Black children

WSS

How a small hospital in rural Puerto Rico survived Hurricane Maria

Some medical students still think black patients feel less pain

Pharma’s losing bet in New Jersey

Louisiana bill approved classifying abortion pills as controlled substances

As health system earnings go up, health insurance stocks go down

Class action alleges UnitedHealth concealed DOJ probe

explore

explore

The next ALS data readout — overdue but important

leisure time

Walensky prepares to leave CDC — and Congress — behind

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Medicare proposal to cover medical devices draws a mixed reaction

Decentralized clinical trials need collaboration to achieve wider use

Anesthesiologist group: stop taking Ozempic before surgery

Bird flu makes raw milk dangerous to consume, mouse study finds

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Clinicians often fail to acknowledge the pain caused by long Covid

As demand for Covid shots wanes, Moderna seeks its next success

HHS's proposed rule does nothing to address the climate crisis

knowledge

Warren pushes Witty on UnitedHealth's control over physicians

PBM executives asked to testify by House panel

Warren pushes Witty on UnitedHealth's control over physicians

Deliver public health messages at the right time

New research sheds light on how often breast cancer is overdiagnosed

Should insurance cover cosmetic surgery?

entertainment

leisure time

explore

hotspot